Related News
Home » Metro » Health and Science
New therapy improves survival rate of colon cancer patients
By Cai Wenjun |
June 21, 2011, Tuesday
|
Online Edition
Online Edition
SHANGHAI Zhongshan Hospital has developed a new therapy which can effectively prevent and control the spread of colon cancer cells to the liver, its doctors told an international colon cancer treatment forum this week in Shanghai.
Colon cancer patients normally have 6.9 months to live if the cancer cells have spread to the liver.
To prevent or delay the liver metastasis, the Zhongshan Hospital applies chemotherapy to both the colon and the liver before cancerous cells start to invade the liver. Data shows the new therapy can reduce the risk of liver metastasis by 55 percent.
Colon cancer has become the second killer cancer after lung cancer in Shanghai due to a changing diet and other unhealthy habits, said Dr Qin Xinyu from the Zhongshan Hospital's surgery department.
China's five-year survival rate of colon cancer patients is 32 percent, compared with 61 percent in the United States and 46 percent in Europe.
The new method invented by the Zhongshan Hospital has been adopted by more than 60 hospitals across China and has been introduced to the medical community abroad.
Colon cancer patients normally have 6.9 months to live if the cancer cells have spread to the liver.
To prevent or delay the liver metastasis, the Zhongshan Hospital applies chemotherapy to both the colon and the liver before cancerous cells start to invade the liver. Data shows the new therapy can reduce the risk of liver metastasis by 55 percent.
Colon cancer has become the second killer cancer after lung cancer in Shanghai due to a changing diet and other unhealthy habits, said Dr Qin Xinyu from the Zhongshan Hospital's surgery department.
China's five-year survival rate of colon cancer patients is 32 percent, compared with 61 percent in the United States and 46 percent in Europe.
The new method invented by the Zhongshan Hospital has been adopted by more than 60 hospitals across China and has been introduced to the medical community abroad.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
